News
Academy
Editorial PodcastsEditorial VideosProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Pharmaceutical Executive APEX Awards
  • Latest Executive Roundtables
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

CPhI’s Pre-Connect Congress Outlines Pharma Trends

August 31, 2016
Article

Pharmaceutical Executive

August 31, 2016

Last week CPhI Worldwide announced the trends to be covered during its CPhI Pre-Connect Congress on Oct. 3, 2016. 

The morning session will be dedicated to drug design and delivery, during which panel discussions will analyze special drug designation with small patient populations-looking at orphan drugs, breakthrough therapies, and highly potent APIs (HPAPIs) across discovery, development, and commercialization. Sessions on cutting edge innovations, model based technologies, and patient-centric design of combination products will complement the agenda.

The congress will also discuss how the changing dynamic of global API manufacturing is forcing manufacturers to innovate and seek new approaches in formulation, sourcing, and manufacturing. Key trends include the tightening of GMP regulations, higher costs through user fees, more stringent requirements for API suppliers in Europe, and the changes continuous processing is bringing.

With a large number of biologics and biosimilars being developed, the biologics track will focus on innovative products and technologies addressing complex disease profiles. The congress will look at the global biosimilars sector including America, Europe, and other emerging markets. Particular emphasis will be placed on the development of Zarxio, the interchangeability of biosimilars, single-use technologies, personalized medicines, and ADCs.

A session will focus on serialization and pharma packaging, including presentations on improving patient care through tamper verification systems, the future of the serialization process, and accessible packaging-focusing on children and elderly patients. The track will also feature regulatory updates on Europe’s Falsified Medicines Directive, and patient adherence and compliance in pharma packaging.

Click here for further information on the Pre-Connect Congress.

Recent Videos
Ted Sweetser
Ted Sweetser
Ted Sweetser
Matthew Yelovich, Cleary Gottlieb, Theranos Case
Related Content

Revenue Optimization: The Money Matters—That Matter Most

Revenue Optimization: The Money Matters—That Matter Most

Jesse Mendelsohn
May 9th 2025
Article

Navigating technology and regulatory shifts in pharma revenue management.


Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.


Stock.adobe.com

FDA Announces ‘Aggressive’ AI Implementation Timeline

Mike Hollan
May 8th 2025
Article

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.


Lunit

Lunit’s AI Technology to Power German Radiology Network

Mike Hollan
May 8th 2025
Article

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.


Faruk Capan

EVERSANA Launches ORCHESTRATE MLR Platform: Q&A with Faruk Capan

Mike Hollan
May 1st 2025
Article

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.


Dan Sheeran

Using AI to Automate Common Tasks: Q&A with Dan Sheeran

Mike Hollan
May 1st 2025
Article

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

Related Content

Revenue Optimization: The Money Matters—That Matter Most

Revenue Optimization: The Money Matters—That Matter Most

Jesse Mendelsohn
May 9th 2025
Article

Navigating technology and regulatory shifts in pharma revenue management.


Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.


Stock.adobe.com

FDA Announces ‘Aggressive’ AI Implementation Timeline

Mike Hollan
May 8th 2025
Article

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.


Lunit

Lunit’s AI Technology to Power German Radiology Network

Mike Hollan
May 8th 2025
Article

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.


Faruk Capan

EVERSANA Launches ORCHESTRATE MLR Platform: Q&A with Faruk Capan

Mike Hollan
May 1st 2025
Article

Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.


Dan Sheeran

Using AI to Automate Common Tasks: Q&A with Dan Sheeran

Mike Hollan
May 1st 2025
Article

Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.

About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.